Anlotinib Capsules in the Treatment for IPF/PF-ILDs
Clinical trial NCT05828953 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05828953
- Sponsor
- First Affiliated Hospital of Wenzhou Medical University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-28
- Primary completion
- 2026-09-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.